Challenges in gathering high quality clinical data and biospecimen for prospective biobanking projects

January 21
1 pm to 2 pm EST

Sponsored by
Trans-Hit Bio logo


Webinar Description:
The emerging need for personalized medicine now requires biobanks to adapt their processes and to add more data to the biospecimen’s collected. Easy access to sample-associated data and a standardized way to record this data is paramount to a quality biobanking service as well-annotated patient clinical information is extremely valuable for research.

Learning Objectives:

  • Understand the need for a software combining clinical data associated and corresponding biospecimen information
  • Understand the importance of maximization of sample value
  • Understand the importance of harmonization of data and sample collection across multiple collecting sites


Thomas J. Moss, MD
The MT Group

Tom Moss is Board Certified Pediatric Hem/Onc/Stem Cell Transplant with an MD from the University of California Medical School. Tom was a primary consultant at Baxter for Isolex CD34 isolation device and also at Immunocon Cell Search Testing. He served as a Senior VP for Impath and was a Co-Founder of the BIS labs CLIA/GLP Micromets and the CMO Cymogen FISH probes. Tom is a Liquid Biopsy Expert/Consultant with 100 peer reviewed publications. Tom was involved in FDA’s approvals for the Isolex Device approval, the Hercept™ test and Cell Search for CTC Analysis. In 2006, he Co-founded The MT Group where he specializes in Prospective Longitudinal Studies, Pseudo clinical trial approach to studies.

Dr. Philippe Vaglio, PhD
Co-Founder and Scientific Advisor

Philippe VAGLIO holds a Ph.D in Biochemistry from Montpellier University and is an expert in the development of software and databases for scientific applications. He was in charge of bioinformatics group in Marc Vidal’s laboratory at the Dana Farber Cancer Institute – Harvard Medical School (Boston USA) where he took part in creating analysis software and databases for the cloning and two-hybrid screening of Caenorhabditis elegans Open Reading Frames (ORF). He was previously responsible for implementing a LIMS for anti-infective molecules screening for RiboTargets in Cambridge, UK. He is a co-founder of Modul-Bio, the only company dedicated to develop software solutions for biological sample management.

Cost: No cost!

Schedule conflict? Register and you'll receive a copy of the recording!